Wockhardt Ltd. benchmarking: Performance to industry peers

Financial

	Wockhardt	JB Chem & Pharma	Pfizer
Operational Metrics
Pharmaceuticals
Domestic Sales Growth - YoY	10.6 %	10.1 %	5.2 %
R&D as a % of Total Sales	2.9 %	1.35 %	n/a
Financials
5 yr Average ROE	4.06 %	17.95 %	19.03 %
5yr average Equity Multiplier	2.02	1.51	1.25
5yr Average Asset Turnover Ratio	0.39	0.76	0.6
5yr Avg Net Profit Margin	-4.28 %	15.74 %	26.04 %
Price to Book	6.11	9.35	4.94
P/E	141.67	54.79	28.72
5yr Avg Cash Conversion Cycle	-94.15 Days	15.08 Days	21.86 Days
Inventory Days	61.29 Days	50.96 Days	49.21 Days
Days Receivable	60.36 Days	72.72 Days	26.06 Days
Days Payable	251.45 Days	94.5 Days	78.13 Days
5yr Average Interest Coverage Ratio	-0.43	76.53	181.67
5yr Avg ROCE	-0.28 %	20.71 %	23.84 %
5yr Avg Operating Profit Margin	5.03 %	24.61 %	31.72 %
5 yr average Debt to Equity	0.56	0.07	0.0
5yr CAGR Net Profit	n/a	12.98 %	74.55 %
5yr Average Return on Assets	-1.79 %	11.91 %	15.25 %
Shareholdings
Promoter Holding	49.08 %	48.8 %	63.92 %
Share Pledged by Promoters	18.82 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	-10.23 %	-5.13 %	0.0
Change in Mutual Fund Holding (3 Yrs)	8.12 %	2.83 %	5.56 %

	Wockhardt	JB Chem & Pharma	Pfizer
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 CDMO 0 API 0 Formulation exported 0 Domestic formulation 0 Pharmaceutical 0	Product Wise Break-Up Contract Manufacturing 10.99 Formulations 28.73 Domestic Formulations 58.22 Active Pharmaceutical Ingredient (API) 1.97 Pharmaceutical 0 Others 0.09	Product Wise Break-Up CDMO 0 Formulation exported 0 Domestic formulation 0 API 0 Pharmaceutical 100.0
Location Wise Break-Up	Location Wise Break-Up Rest of the World 36.17 India 19.79 Europe 0 USA 0 Russia 0 South Africa 0 Others 44.04	Location Wise Break-Up Rest of the World 42.09 South Africa 0 USA 0 Europe 0 India 57.91 Russia 0	Location Wise Break-Up Rest of the World 5.0 South Africa 0 USA 0 Europe 0 India 95.0 Russia 0
Asset Break-Up	Asset Break-Up Others 100	-	-